Skip to content

Investigating the combined therapeutic effect of mesenchymal stem cells and condition media to increase endometrial thickness in infertile women with thin endometrium

Investigating the combined therapeutic effect of mesenchymal stem cells and condition media to increase endometrial thickness in infertile women with thin endometrium

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230222057500N2
Enrollment
40
Registered
2024-10-06
Start date
2024-11-05
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility with thin endometrium. Female infertility of uterine origin

Interventions

Intervention 1: Intervention group 1: patients will be received a sub-endometrium injection of 10 million mesenchymal stem cells with an oocyte puncture needle and two intrauterine injections of 1 ml

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 48 Years

Inclusion criteria

Inclusion criteria: Infertile women with thin endometrium patient with thin endometrium for whom drugs and other treatments were ineffective Endometrial thickness less than 7 mm Embryo transfer is cancelled because of thin endometrium Age between 20 and 44 years HBsAg negative, HCV negative, HIV negative, CMV negative

Exclusion criteria

Exclusion criteria: Abnormal karyotype Contraindications to hormone replacement therapy Systemic diseases such as hypertension, diabetes Other uterine diseases including uterine malformations, large myoma, endometrial tuberculosis, endometriosis Autoimmune diseases such as rheumatoid arthritis, lupus Unable to adhere to the follow-up

Design outcomes

Primary

MeasureTime frame
Endometrium thickness. Timepoint: Before the intervention and 1, 2 and 3 months after the first intervention Method of measurement. Method of measurement: Vaginal sonography.

Secondary

MeasureTime frame
Endometrial thickness. Timepoint: 15 days after embryo transfer. Method of measurement: Using sonography and serum beta-human chorionic gonadotropin level assessment by enzyme-linked immunosorbent assay (ELISA) or chemi luminescence.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeedeh Torabi Goudarzi

Tehran University of Medical Sciences

torabig@razi.tums.ac.ir+98 21 4305 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026